Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 319 of 1,261
  1. US 11103572

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  2. US 11103532

    Chimeric protein

    AUTOLUS LIMITED · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  3. US 11103514

    Treatment of muscular dystrophy

    Corcept Therapeutics Incorporated · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  4. US 11103528

    Slow release calcium composition

    United States of America as represented by the Secretary of the Air Force · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  5. US 11103523

    Self-assembled brush block copolymer-nanoparticles for drug delivery

    UNIVERSITY OF CONNECTICUT · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  6. US 11103520

    Analogs of N-acetlyglucosamine and uses thereof

    The Regents of the University of California · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  7. US 11103504

    Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment

    ACADEMISCH MEDISCH CENTRUM · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  8. US 11103491

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  9. US 11103479

    Small organic molecules for use in the treatment of neuroinflammatory disorders

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  10. US 11103461

    Process for encapsulating soluble biologics, therapeutics, and imaging agents

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  11. CA 3168610

    MASITINIB POUR LE TRAITEMENT D'UNE SOUS-POPULATION DE PATIENTS SOUFFRANT DE SCLEROSE EN PLAQUES

    AB SCIENCE [FR] · Granted Aug 26, 2021 · Expires Aug 21, 2041

    granted
  12. US 11098052

    4-azapodophylotoxins compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  13. US 11098042

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  14. US 11098054

    Englerin derivatives for treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Sciences · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  15. US 11098109

    Single-chain variable fragment anti-CD133 antibodies and uses thereof

    Regents of the University of Minnesota · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  16. US 11098126

    Anti-MET antibodies and uses thereof

    AGOMAB THERAPEUTICS BVBA · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  17. US 11098283

    T cells modified to overexpress c-Myb

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  18. US 11096996

    Cancer vaccines and vaccination methods

    Precision Lifesciences Group LLC · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  19. US 11097012

    Biodegradable vectors for efficient RNA delivery

    The Regents of the University of California · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  20. US 11096964

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Fate Therapeutics, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  21. US 11096954

    Bisphosphocin gel formulations and uses thereof

    Lakewood Amedex, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  22. US 11096910

    Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease

    The Board of Regents of the University of Texas System · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  23. US 11098107

    Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

    Sutro Biopharma, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  24. US 11098311

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.